{"id":136030,"date":"2026-10-29T13:13:39","date_gmt":"2026-10-29T04:13:39","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4549-20261029-01_wp_financial_summary\/"},"modified":"2026-10-29T13:13:39","modified_gmt":"2026-10-29T04:13:39","slug":"4549-20261029-01_wp_financial_summary","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/","title":{"rendered":"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027"},"content":{"rendered":"<p>For the second quarter, net sales were 21,388 million yen, up 4.7% year-over-year; operating income was 1,587 million yen, down -8.2%; ordinary income was 1,616 million yen, down -6.6%; and interim net income attributable to owners of parent was 1,125 million yen, down -62.2%. Full-year forecasts remain unchanged from the previous announcement. No information on share buybacks is provided. Dividends are maintained at 29 yen at the end of the second quarter, unchanged from the prior year, with a full-year forecast of 58 yen. Financial position: total assets 64,023 million yen, net assets 44,247 million yen, and equity ratio 69.1%. Major asset and liability breakdowns are disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4549","jir_company_name":"Eiken Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4549-20261029-01.pdf","jir_short_summary":"For the second quarter, net sales were 21,388 million yen, up 4.7% year-over-year; operating income was 1,587 million yen, down -8.2%; ordinary income was 1,616 million yen, down -6.6%; and interim net income attributable to owners of parent was 1,125 million yen, down -62.2%. Full-year forecasts remain unchanged from the previous announcement. No information on share buybacks is provided. Dividends are maintained at 29 yen at the end of the second quarter, unchanged from the prior year, with a full-year forecast of 58 yen. Financial position: total assets 64,023 million yen, net assets 44,247 million yen, and equity ratio 69.1%. Major asset and liability breakdowns are disclosed.","jir_summary":"### Overview of Results\nNet sales for the interim period were 21,388 million yen (YoY +4.7%), securing revenue growth. Meanwhile, operating income was 1,587 million yen (YoY -8.2%) and ordinary income was 1,616 million yen (YoY -6.6%), reflecting a decline due to the impact of one-off special income in the prior-year period and changes in business composition. Interim net income attributable to owners of parent was 1,125 million yen (YoY -62.2%), a substantial decrease. There have been no major revisions to the initial forecasts, and the full-year projections remain unchanged. Financial soundness is maintained with total assets of 64,023 million yen, net assets of 44,247 million yen, and an equity ratio of 69.1%.\n\n### Dividends, Capital Policy and Outlook\nAnnual dividend is expected to remain at 29 yen at the second quarter-end and 58 yen for the full year. The financial summary is presented as a \"financial\" report, and no changes to dividend policy have been announced. Earnings forecasts remain as previously disclosed; while there is room for short-term improvement in profitability, the long-term strategy focusing on areas such as \"contribution to cancer prevention and treatment\" toward 2030 will continue.","jir_financial_highlights":"Net Sales: 21,388 million yen (Year-over-Year (YoY) +4.7%)\nOperating Income: 1,587 million yen (Year-over-Year (YoY) -8.2%)\nOrdinary Income: 1,616 million yen (Year-over-Year (YoY) -6.6%)\nNet Income Attributable to Owners of Parent (Interim): 1,125 million yen (Year-over-Year (YoY) -62.2%)\nTotal Assets: 64,023 million yen\nNet Assets: 44,247 million yen","jir_category":"","jir_hashtags":"#EikenChemical, #FinancialResults, #InterimResults, #FinancialPosition, #DividendPolicy","jir_key_figures":"Net Sales: 21,388 million yen (Year-over-Year +4.7%)\nOperating Income: 1,587 million yen (Year-over-Year -8.2%)\nNet Income Attributable to Owners of Parent (Interim): 1,125 million yen (Year-over-Year -62.2%)","jir_meta_title":"Eiken Chemical Co., Ltd. \u2014 Q2 Financial Summary for FY Mar 2027 | Net Sales 21,388 million yen (YoY +4.7%)","jir_meta_description":"Financial summary for Eiken Chemical Co., Ltd. for the second quarter of FY Mar 2027. Net sales: 21,388 million yen; operating income: 1,587 million yen; net income: 1,125 million yen. Full-year forecast unchanged; dividend forecast 58 yen. Total assets: 64,023 million yen; equity ratio: 69.1%.","jir_og_title":"Eiken Chemical Co., Ltd. \u2014 Q2 Financial Summary FY Mar 2027","jir_og_description":"Eiken Chemical Co., Ltd. second quarter results: net sales 21,388 million yen. Profits declined but full-year forecast is maintained. Dividend forecast 58 yen. Financial position remains stable.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[214.3,210.0,213.9,218.8]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[16.9,18.0,15.9,15.9]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Interim Net Income Attributable to Owners of Parent Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Interim Net Income\\\",\\\"data\\\":[29.79,31.05,11.25,11.25]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"assets_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Assets Composition\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Current Assets\\\",\\\"Non-current Assets\\\"],\\\"datasets\\\":[{\\\"data\\\":[34.133,29.890]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"liabilities_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Liabilities Composition\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Current Liabilities\\\",\\\"Non-current Liabilities\\\"],\\\"datasets\\\":[{\\\"data\\\":[15.84,3.94]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"dividend_policy_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Dividend Policy Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026\\\",\\\"FY2027 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Annual Dividend\\\",\\\"data\\\":[58,58]}]},\\\"options\\\":{}}\"}]","ir_related_company":16754,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-136030","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/\",\"name\":\"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-10-29T04:13:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/","url":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/","name":"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027 - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-10-29T04:13:39+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4549\/ir\/4549-20261029-01_wp_financial_summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"16754","title":"EIKEN CHEMICAL CO","ticker":"4549"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/136030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=136030"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/136030\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=136030"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=136030"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=136030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}